FFCP PHASE1:Hg19::chr11:89223721..89223728,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=NA | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=novel_noncoding | |||
|HGNC=NA | |||
|TSSclassifier=strong | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|coexpression_cluster_id=C117 | |||
|description=CAGE_peak_at_chr11:89223721..89223728,- | |||
|id=chr11:89223721..89223728,- | |||
|ontology_enrichment_celltype=CL:0000313!2.16e-26!1;CL:0002557!5.93e-26!1;CL:0000159!6.43e-14!2 | |||
|ontology_enrichment_celltype_v019=CL:0000313;5.42e-195;1!CL:0000159;1.55e-98;2 | |||
|ontology_enrichment_celltype_v019_2=CL:0000313,5.42e-195,1;CL:0000159,1.55e-98,2;CL:0000151,5.81e-07,36 | |||
|ontology_enrichment_development_v019=UBERON:0009117;3.81e-21;10!UBERON:0005564;3.81e-21;10 | |||
|ontology_enrichment_disease=DOID:2152!2.16e-26!1 | |||
|ontology_enrichment_disease_v019=DOID:2152;5.42e-195;1!DOID:2394;1.43e-15;14!DOID:299;2.15e-09;25!DOID:120;8.32e-09;27!DOID:193;2.67e-08;29 | |||
|ontology_enrichment_disease_v019_2=DOID:2152,5.42e-195,1;DOID:2394,1.43e-15,14;DOID:299,2.15e-09,25;DOID:120,8.32e-09,27;DOID:193,2.67e-08,29 | |||
|ontology_enrichment_uberon=UBERON:0004911!2.16e-26!1;UBERON:0009722!7.00e-21!11;UBERON:0007690!7.00e-21!11;UBERON:0002046!9.93e-21!5;UBERON:0004117!9.93e-21!5;UBERON:0007689!9.93e-21!5;UBERON:0007123!9.93e-21!5;UBERON:0003091!9.93e-21!5;UBERON:0008814!1.59e-15!15;UBERON:0004909!6.43e-14!2;UBERON:0007497!1.07e-13!2;UBERON:0003643!1.07e-13!2;UBERON:0003504!1.07e-13!2;UBERON:0003469!1.07e-13!2;UBERON:0003496!1.07e-13!2;UBERON:0004797!1.07e-13!2;UBERON:0002012!1.07e-13!2;UBERON:0008886!1.07e-13!2;UBERON:0007303!1.07e-13!2;UBERON:0002061!1.07e-13!2;UBERON:0005432!1.07e-13!2;UBERON:0004363!1.07e-13!2;UBERON:0010188!1.41e-09!3;UBERON:0002539!1.41e-09!3;UBERON:0004145!1.41e-09!3;UBERON:0008816!1.41e-09!3 | |||
|ontology_enrichment_uberon_v019=UBERON:0004911;5.42e-195;1!UBERON:0004909;1.55e-98;2!UBERON:0000992;1.21e-16;13!UBERON:0000991;6.74e-11;21!UBERON:0000474;2.32e-07;37 | |||
|ontology_enrichment_uberon_v019_2=UBERON:0004911,5.42e-195,1;UBERON:0004909,1.55e-98,2;UBERON:0000992,1.21e-16,13;UBERON:0000991,6.74e-11,21;UBERON:0009196,6.74e-11,21;UBERON:0009117,6.74e-11,21;UBERON:0005564,6.74e-11,21;UBERON:0004176,1.80e-10,22;UBERON:0003134,8.21e-07,37;UBERON:0000474,8.21e-07,37 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0654895377488563,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.366403487860815,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.113432183160021,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.157611414598396,0.0524545881349981,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,3.24380752213598,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0636471582781649,0.202117188958219,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr11:89223721..89223728,- | |||
}} |
Revision as of 09:48, 11 January 2014
Short description: | p@chr11:89223721..89223728, - |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_at_chr11:89223721..89223728, - |
Coexpression cluster: | C117_serous_clear_kidney_neuroectodermal_mesothelioma_endometrial_Intestinal |
Association with transcript: | NA |
EntrezGene: | NA |
HGNC: | NA |
UniProt: | NA |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
serous secreting cell | 5.42e-195 | 1 |
seromucus secreting cell | 1.55e-98 | 2 |
secretory cell | 5.81e-07 | 36 |
Ontology term | p-value | n |
---|---|---|
epithelium of female gonad | 5.42e-195 | 1 |
epithelium of gonad | 1.55e-98 | 2 |
female gonad | 1.21e-16 | 13 |
gonad | 6.74e-11 | 21 |
indifferent external genitalia | 6.74e-11 | 21 |
indifferent gonad | 6.74e-11 | 21 |
gonad primordium | 6.74e-11 | 21 |
external genitalia | 1.80e-10 | 22 |
female reproductive organ | 8.21e-07 | 37 |
female reproductive system | 8.21e-07 | 37 |
Ontology term | p-value | n |
---|---|---|
ovary epithelial cancer | 5.42e-195 | 1 |
ovarian cancer | 1.43e-15 | 14 |
adenocarcinoma | 2.15e-09 | 25 |
female reproductive organ cancer | 8.32e-09 | 27 |
reproductive organ cancer | 2.67e-08 | 29 |